CERo Therapeutics Holdings (CERo Therapeutics Holdings) Other Stockholders Equity : $-0.00 Mil (As of Dec. 2022)

View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Other Stockholders Equity?

CERo Therapeutics Holdings's Other Stockholders Equity for the quarter that ended in Dec. 2022 was $-0.00 Mil.

CERo Therapeutics Holdings's quarterly Other Stockholders Equity stayed the same from . 20 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil).

CERo Therapeutics Holdings's annual Other Stockholders Equity stayed the same from . 20 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil).

CERo Therapeutics Holdings Other Stockholders Equity Historical Data

The historical data trend for CERo Therapeutics Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Other Stockholders Equity Chart

CERo Therapeutics Holdings Annual Data

Trend

Dec21

Dec22

Other Stockholders Equity

CERo Therapeutics Holdings Semi-Annual Data
	Dec21	Dec22
Other Stockholders Equity	-	-

CERo Therapeutics Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

CERo Therapeutics Holdings Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080

Website

https://www.cero.bio

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024